World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
29382
World Ranking
8369
National Ranking
4326

B. Mark Evers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where B. Mark Evers sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 592 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

B. Mark Evers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where B. Mark Evers sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2020 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

B. Mark Evers is affiliated with the University of Kentucky in the United States. Their research primarily spans the fields of medicine and biochemistry, genetics, and molecular biology, with notable contributions in molecular biology, oncology, cancer research, epidemiology, and surgery. The scientist's recent publications reflect a focus on cancer biology, cellular metabolism, and molecular mechanisms involved in tumor development and progression.

Among recent papers, key works include:

  • "Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy," 2020, published in Nature Communications
  • "Spermine synthase and MYC cooperate to maintain colorectal cancer cell survival by repressing Bim expression," 2020, published in Nature Communications
  • "Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells," 2020, published in Frontiers in Oncology
  • "Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer," 2020, published in Cell Death and Disease
  • "SIRT2 Contributes to the Regulation of Intestinal Cell Proliferation and Differentiation," 2020, published in Cellular and Molecular Gastroenterology and Hepatology

The scientist collaborates frequently with several researchers, including Heidi L. Weiss, Piotr Rychahou, Tianyan Gao, Chi Wang, and Daheng He. These coauthors have been associated with multiple joint publications, indicating ongoing collaborations in their areas of expertise.

Major publication venues where B. Mark Evers has contributed extensively include:

  • Gastroenterology
  • Cancer Research
  • Cells
  • Cell Death and Disease
  • Cellular and Molecular Gastroenterology and Hepatology

Research topics covered in the body of their work encompass cancer-related mechanisms and metabolic processes, with particular emphasis on:

  • Cancer, Hypoxia, and Metabolism
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Neuropeptides and Animal Physiology
  • Cancer, Lipids, and Metabolism
  • RNA modifications and cancer

B. Mark Evers has received recognition for their professional contributions, including election as a Member of the National Academy of Medicine in 2020 and membership in the Association of American Physicians.

Best Publications

  • Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion

    Yadi Wu;Jiong Deng;Piotr G. Rychahou;Suimin Qiu

  • Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

    Chenfang Dong;Tingting Yuan;Yadi Wu;Yifan Wang

  • mTORC1 and mTORC2 regulate EMT, motility and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

    Pat Gulhati;Kanika A. Bowen;Jianyu Liu;Payton D. Stevens

  • Disrupting the Interaction of BRD4 With Diacetylated Twist Suppresses Tumorigenesis in Basal-Like Breast Cancer

    Jian Shi;Yifan Wang;Yifan Wang;Lei Zeng;Yadi Wu

  • G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer

    Chenfang Dong;Yadi Wu;Jun Yao;Yifan Wang

  • FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.

    Vijayanand Modur;Rakesh Nagarajan;B. Mark Evers;Jeffrey Milbrandt

  • Inflammation and the development of pancreatic cancer.

    Buckminster Farrow;B.Mark Evers

  • Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression

    Fengmei Pi;Daniel W. Binzel;Tae Jin Lee;Tae Jin Lee;Zhefeng Li

  • The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1

    Yiwei Lin;Yadi Wu;Junlin Li;Chenfang Dong

  • mTOR inhibitors in cancer therapy

    Yekaterina Y. Zaytseva;Joseph D. Valentino;Prateek gulhati;B. Mark Evers

  • Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway

    Shawn D. Larson;Lindsey N. Jackson;Taylor S. Riall;Tatsuo Uchida

  • Novel Expression Patterns of PI3K/AKT/mTOR Signaling Pathway Components in Colorectal Cancer

    Sara M. Johnson;Pat Gulhati;Pat Gulhati;Bill A. Rampy;Yimei Han

  • Stable RNA nanoparticles as potential new generation drugs for cancer therapy

    Yi Shu;Fengmei Pi;Ashwani Sharma;Mehdi Rajabi

  • Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas

    Xiaoli Ma;Kai Chen;Shuhong Huang;Xiaoli Zhang

  • Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth.

    B.Mark Evers;Courtney M. Townsend;J.Robert Upp;Erick Allen

  • An obligatory role for neurotensin in high-fat-diet-induced obesity

    Jing Li;Jun S. Song;Yekaterina Y. Zaytseva;Yajuan Liu

  • Prostaglandin E2 Stimulates the Growth of Colon Cancer Cells via Induction of Amphiregulin

    Jinyi Shao;Sean B Lee;Huiping Guo;B Mark Evers

  • Ultrastable Synergistic Tetravalent RNA Nanoparticles for Targeting to Cancers

    Farzin Haque;Dan Shu;Yi Shu;Luda S. Shlyakhtenko

  • Inflammatory mechanisms contributing to pancreatic cancer development.

    Buckminster Farrow;Yuko Sugiyama;Andy Chen;Ekong Uffort

  • Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis

    Piotr G. Rychahou;Junghee Kang;Prateek gulhati;Hung Quoc Doan

Frequent Co-Authors

Heidi L. Weiss
Heidi L. Weiss University of Kentucky
Binhua P. Zhou
Binhua P. Zhou University of Kentucky
Peixuan Guo
Peixuan Guo The Ohio State University
Andrew J. Morris
Andrew J. Morris University of Kentucky
Teresa W.-M. Fan
Teresa W.-M. Fan University of Kentucky
D. Allan Butterfield
D. Allan Butterfield University of Kentucky
Haining Zhu
Haining Zhu University of Arizona
Paul Angulo
Paul Angulo University of Kentucky
Lei Zeng
Lei Zeng Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a variety of rewarding careers. For those seeking flexibility, numerous accredited online programs now make advanced healthcare education more accessible than ever.

If you're interested in nursing leadership, consider the cheapest dnp online programs. These programs allow registered nurses to earn a Doctor of Nursing Practice degree online without a huge financial burden.

Aspiring pharmacists can pursue an online pharmacy degree, providing the necessary credentials to thrive in pharmaceutical careers. These online degrees often offer flexible scheduling for busy students.

For those drawn to the administrative side of medicine, an online health information management degree can lead to positions in health data management, compliance, and healthcare analytics.

Entry-level learners might consider earning a medical coding certification online. This pathway is ideal for those wanting to quickly start a career in medical records and billing without a lengthy degree.

Best Scientists Citing B. Mark Evers

Trending Scientists

Recently Published Articles